// App-Quantinova.ai

: Model of Short and Long-Term Outcomes of Emicizumab Prophylaxis Treatment for Persons with Hemophilia Α

Researchers

Presenter

  • Arash Mahajerin

Principal Investigators

  • Zheng-Yi Zhou

  • Karina Raimundo

  • Anisha Patel

  • Simeng Han

  • Yusi Ji

  • Jia Zhong

  • Keith Betts

Medical Centers

  • CHOC Childrens Hospital, Orange, CA

  • Analysis Group, Inc., London, United Kingdom

  • Genentech, Inc., South San Francisico, CA

  • Analysis Group Inc., Beijing, China

  • Analysis Group, Inc., Los Angeles, CA

Locations

  • United States

  • United Kingdom

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

Disease

  • Hemophilia

Biomarkers

  • N/A

Drug/Treatment

  • FVIII

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved